Anandia Labs is a leader in cannabis testing, extraction and genetics, using genomics and modern plant breeding approaches to develop innovative products and next generation varieties. The company holds key intellectual property positions including cannabinoid pathway patents and is the only independent Canadian testing facility specializing exclusively in cannabis. With its Health Canada dealer’s license in hand, Anandia Labs has the seal of approval to undertake research and development, and to develop products beyond those currently permitted for licensed producers under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR).
Bodhi Research is conducting a research trial into the use of cannabis in the treatment of concussion and post-concussive syndrome, under the direction of Dr. Neilank Jha, Neurosurgeon, Editor in Chief of Current Research: Concussion, and Chair of The Konkussion Retreat.
BAS is a medical cannabis manufacturing and research group, developing advanced science-driven medical cannabis products. BAS also delivers leading edge quality and safety testing services.